The BRIDGE program, coordinated by the Kirby Institute and UNSW Sydney, aims to advance Australian RNA research and bring new treatments to market. It supports RNA-based therapeutics development through partnerships, infrastructure, and a structured pipeline from proof-of-concept to clinical trials. The program collaborates with various institutions and includes a consumer representative for patient feedback.